trending Market Intelligence /marketintelligence/en/news-insights/trending/x12excv9azr6osdau_xp4g2 content esgSubNav
In This List

Ampio Pharmaceuticals chief scientific officer to retire

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Ampio Pharmaceuticals chief scientific officer to retire

Ampio Pharmaceuticals Inc. said David Bar-Or will retire as chief scientific officer, effective Sept. 30.

Bar-Or will remain on the Englewood, Colo.-based biopharmaceutical company's board.

He said he plans to do some projects at the Trauma Research Center where he serves as research director for eight medical institutions.